BONADONNA, PATRIZIA
 Distribuzione geografica
Continente #
NA - Nord America 3.464
EU - Europa 2.716
AS - Asia 1.924
SA - Sud America 234
Continente sconosciuto - Info sul continente non disponibili 64
AF - Africa 51
OC - Oceania 10
Totale 8.463
Nazione #
US - Stati Uniti d'America 3.358
RU - Federazione Russa 964
SG - Singapore 673
CN - Cina 639
GB - Regno Unito 534
IT - Italia 330
SE - Svezia 204
VN - Vietnam 168
BR - Brasile 167
DE - Germania 147
HK - Hong Kong 144
FR - Francia 132
IE - Irlanda 116
FI - Finlandia 108
BD - Bangladesh 70
CA - Canada 60
KR - Corea 59
NL - Olanda 48
IN - India 34
UA - Ucraina 24
AR - Argentina 22
JP - Giappone 22
PL - Polonia 20
ES - Italia 18
TR - Turchia 17
BE - Belgio 16
ID - Indonesia 16
MX - Messico 14
ZA - Sudafrica 13
VE - Venezuela 12
CL - Cile 11
IQ - Iraq 11
AT - Austria 10
EC - Ecuador 10
IL - Israele 10
AU - Australia 9
CH - Svizzera 7
NG - Nigeria 7
TN - Tunisia 7
CR - Costa Rica 6
LT - Lituania 6
MA - Marocco 6
PK - Pakistan 6
CO - Colombia 5
CZ - Repubblica Ceca 5
IR - Iran 5
MY - Malesia 5
RO - Romania 5
UZ - Uzbekistan 5
HN - Honduras 4
KZ - Kazakistan 4
SC - Seychelles 4
CW - ???statistics.table.value.countryCode.CW??? 3
DK - Danimarca 3
GR - Grecia 3
JM - Giamaica 3
JO - Giordania 3
NO - Norvegia 3
NP - Nepal 3
OM - Oman 3
PR - Porto Rico 3
PT - Portogallo 3
SA - Arabia Saudita 3
SI - Slovenia 3
SV - El Salvador 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BJ - Benin 2
BO - Bolivia 2
CG - Congo 2
DZ - Algeria 2
GT - Guatemala 2
KE - Kenya 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LK - Sri Lanka 2
LV - Lettonia 2
NI - Nicaragua 2
PE - Perù 2
PH - Filippine 2
PS - Palestinian Territory 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AW - Aruba 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
CD - Congo 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
GP - Guadalupe 1
HR - Croazia 1
Totale 8.390
Città #
Ashburn 484
Southend 436
Moscow 350
Singapore 347
Chandler 314
San Jose 294
Dallas 280
Woodbridge 191
Beijing 175
Hong Kong 142
Ann Arbor 124
Jacksonville 121
Dublin 116
Council Bluffs 99
Verona 95
Houston 90
New York 79
The Dalles 75
Los Angeles 57
Wilmington 55
Ho Chi Minh City 50
Lawrence 46
Princeton 46
Hanoi 42
Jinan 38
Nanjing 33
Helsinki 30
Shenyang 29
Santa Clara 25
Denver 24
Bologna 23
Groningen 22
Milan 22
Redondo Beach 22
Columbus 20
Tokyo 20
Munich 19
Atlanta 17
Buffalo 17
Rome 17
São Paulo 17
Brussels 16
Hebei 16
Tianjin 16
Warsaw 16
Chicago 15
Ningbo 14
Seattle 14
Taizhou 14
Zhengzhou 14
Guangzhou 13
Haikou 13
Sindelfingen 13
Changsha 12
Chennai 12
Hangzhou 12
Seoul 12
Turku 12
Amsterdam 11
Jiaxing 11
London 11
Redwood City 11
Taiyuan 11
Johannesburg 10
Montreal 10
Orem 10
Brooklyn 9
Manchester 9
Norwalk 9
Stockholm 9
Belo Horizonte 8
Dong Ket 8
Frankfurt am Main 8
Nanchang 8
Phoenix 8
San Francisco 8
Toronto 8
Baghdad 7
Boardman 7
Boston 7
Dearborn 7
Mexico City 7
Santa Fe 7
Shanghai 7
Bonn 6
Düsseldorf 6
Lanzhou 6
Poplar 6
Washington 6
Abuja 5
Ardabil 5
Augusta 5
Barnet 5
Catania 5
Charlotte 5
Fairfield 5
Falkenstein 5
Haiphong 5
Hải Dương 5
Jakarta 5
Totale 5.048
Nome #
Epidemiology of mastocytosis in adults based on a multidisciplinary diagnostic approach. 357
Anaphylactic Reactions After Discontinuation of Hymenoptera Venom Immunotherapy: A Clonal Mast Cell Disorder Should Be Suspected 253
Clonal mast cell disorders limited to bone marrow: not a negligible disease. 253
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 241
A simple score predicts clonal mast cell disorders in patients with systemic reactions to Hymenoptera venom without skin lesions 231
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 225
Allergic Reactions to COVID-19 Vaccines: Risk Factors, Frequency, Mechanisms and Management 224
Value of flow cytometry in the diagnosis of indolent systemic mastocytosis. 224
Bone involvement and osteoporosis in mastocytosis. 218
Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels 217
Bone involvement in patient with clonal mast cell disorders 210
Somatic D816V KIT mutation in a case of adult-onset familial mastocytosis. 204
A Multidisciplinary Diagnostic Approach Reveals a Higher Prevalence of Indolent Systemic Mastocytosis: 15-Years’ Experience of the GISM Network 203
A Survey on Clinical and Biological Characteristic and Therapy Management of an Italian Series of 455 Adult Patients with Systemic Mastocytosis on Behalf of Italian Registry of Mastocytosis 201
Improved detection of the C-KIT D816V mutation using allele-specific arms real time PCR assay allows a finer recognition of patients with indolent systemic mastocytosis. 200
Underdiagnosed systemic mastocytosis: The role of flow cytometry 196
The impact of sensitive KIT D816V detection on recognition of Indolent Systemic Mastocytosis 191
Osteopetrosi 190
Cross reactivity between European hornet and yellow jacket venoms 188
Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis 176
Prevalence of osteoporosis in patients affected by mastocytosis 176
Multiple large osteolytic lesions in a patient with systemic mastocytosis: a challenging diagnosis 176
Serum tryptase levels differently change over time in indolent systemic mastocytosis with or without skin lesions. 176
Ultra-deep sequencing (UDS) allows more sensitive detection of the D816V and other KIT gene mutations in systemic mastocytosis 175
CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis 170
Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients 169
Systemic mastocytosis: a muldisciplinary approach (Review) [Lamastocitosi sistemica: Un approccio multidiscliplinare] 167
Vaccination Management In Children and Adults With Mastocytosis 165
The Italian Mastocytosis Registry: 6-year experience from a hospital-based registry 164
Hymenoptera Anaphylaxis and C-kit Mutations: An Unexpected Association 159
Anxiety and Depression Effects During Drug Provocation Test 158
Ultra-Deep Sequencing (UDS) Allows More Sensitive Detection of the D816V and Other Kit Gene Mutations in Systemic Mastocytosis 156
Drug allergy passport and other documentation for patients with drug hypersensitivity - An ENDA/EAACI Drug Allergy Interest Group Position Paper 155
International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study 151
Male osteoporosis and hymenoptera venom anaphylaxis [Osteoporosi maschile e anafilassi da imenotteri] 147
Timing of response and long term efficacy of Omalizumab in non-clonal Mast Cell Activation Syndrome: A case series 146
Mastocytosis and allergic diseases 143
Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification 140
Zoledronic Acid in Osteoporosis Secondary to Mastocytosis. 138
Skeletal implications of isolated bone marrow mastocytosis (reply): Indolent systemic mastocytosis without skin involvement vs. isolated bone marrow mastocytosis (reply) 136
Mast Cell Disorders In Drug Hypersensitivity 134
Hymenoptera Allergy and Mast Cell Activation Syndromes 130
Wasp venom allergy screening with recombinant allergen testing. Diagnostic performance of rPol d 5 and rVes v 5 for differentiating sensitization to Vespula and Polistes subspecies 124
The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and Perspectives 114
Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM 110
Mastocytosis and insect venom allergy 107
Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis 58
Prognostic Impact of Organomegaly in Mastocytosis: An Analysis of the European Competence Network on Mastocytosis 57
null 44
Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM 16
Totale 8.463
Categoria #
all - tutte 28.168
article - articoli 21.562
book - libri 0
conference - conferenze 6.606
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.336


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022181 0 0 0 0 21 11 9 22 17 12 21 68
2022/2023853 61 97 65 166 54 218 16 50 102 4 12 8
2023/2024437 37 32 26 34 45 69 23 47 5 30 71 18
2024/20251.007 40 72 82 173 41 25 50 45 151 69 87 172
2025/20263.284 215 170 250 540 798 204 279 169 258 212 98 91
2026/2027741 65 98 138 354 86 0 0 0 0 0 0 0
Totale 8.463